137 related articles for article (PubMed ID: 18765693)
1. Interspecies recombination occurs frequently in quinolone resistance-determining regions of clinical isolates of Streptococcus pyogenes.
Duesberg CB; Malhotra-Kumar S; Goossens H; McGee L; Klugman KP; Welte T; Pletz MW
Antimicrob Agents Chemother; 2008 Nov; 52(11):4191-3. PubMed ID: 18765693
[TBL] [Abstract][Full Text] [Related]
2. Fluoroquinolone resistance in Streptococcus dysgalactiae subsp. equisimilis and evidence for a shared global gene pool with Streptococcus pyogenes.
Pinho MD; Melo-Cristino J; Ramirez M;
Antimicrob Agents Chemother; 2010 May; 54(5):1769-77. PubMed ID: 20145082
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of fluoroquinolone-nonsusceptible Streptococcus pyogenes emm12 in Taiwan.
Lin JN; Chang LL; Lai CH; Huang YH; Chen WF; Yang CH; Hsu J; Lin HH; Chen YH
Diagn Microbiol Infect Dis; 2015 Oct; 83(2):187-92. PubMed ID: 26234479
[TBL] [Abstract][Full Text] [Related]
4. Fluoroquinolone resistance in invasive Streptococcus pyogenes isolates due to spontaneous mutation and horizontal gene transfer.
Pletz MW; McGee L; Van Beneden CA; Petit S; Bardsley M; Barlow M; Klugman KP
Antimicrob Agents Chemother; 2006 Mar; 50(3):943-8. PubMed ID: 16495255
[TBL] [Abstract][Full Text] [Related]
5. An intrinsic pattern of reduced susceptibility to fluoroquinolones in pediatric isolates of Streptococcus pyogenes.
Yan SS; Schreckenberger PC; Zheng X; Nelson NA; Harrington SM; Tjhio J; Fedorko DP
Diagn Microbiol Infect Dis; 2008 Oct; 62(2):205-9. PubMed ID: 18554840
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and characterization of invasive isolates of Streptococcus pyogenes with reduced susceptibility to fluoroquinolones.
Powis J; McGeer A; Duncan C; Goren R; de Azavedo JC; Bast DJ; Pong-Porter S; Mazzulli T; Green K; Willey B; Low DE
Antimicrob Agents Chemother; 2005 May; 49(5):2130-2. PubMed ID: 15855546
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics.
Orscheln RC; Johnson DR; Olson SM; Presti RM; Martin JM; Kaplan EL; Storch GA
J Infect Dis; 2005 Apr; 191(8):1272-9. PubMed ID: 15776373
[TBL] [Abstract][Full Text] [Related]
8. Emergence of fluoroquinolone-resistant Streptococcus pyogenes in Japan by a point mutation leading to a new amino acid substitution.
Arai K; Hirakata Y; Yano H; Kanamori H; Endo S; Hirotani A; Abe Y; Nagasawa M; Kitagawa M; Aoyagi T; Hatta M; Yamada M; Nishimaki K; Takayama Y; Yamamoto N; Kunishima H; Kaku M
J Antimicrob Chemother; 2011 Mar; 66(3):494-8. PubMed ID: 21172783
[TBL] [Abstract][Full Text] [Related]
9. Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations.
Smeesters PR; Vergison A; Junior DC; Van Melderen L
Int J Antimicrob Agents; 2009 Jul; 34(1):44-9. PubMed ID: 19269141
[TBL] [Abstract][Full Text] [Related]
10. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
[TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolone resistance in Streptococcus pyogenes.
Richter SS; Diekema DJ; Heilmann KP; Almer LS; Shortridge VD; Zeitler R; Flamm RK; Doern GV
Clin Infect Dis; 2003 Feb; 36(3):380-3. PubMed ID: 12539083
[TBL] [Abstract][Full Text] [Related]
12. Increase in fluoroquinolone non-susceptibility among clinical Streptococcus pyogenes in Belgium during 2007-10.
Van Heirstraeten L; Leten G; Lammens C; Goossens H; Malhotra-Kumar S
J Antimicrob Chemother; 2012 Nov; 67(11):2602-5. PubMed ID: 22815354
[TBL] [Abstract][Full Text] [Related]
13. Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
Pires R; Ardanuy C; Rolo D; Morais A; Brito-Avô A; Gonçalo-Marques J; Liñares J; Santos-Sanches I
Antimicrob Agents Chemother; 2010 Jun; 54(6):2677-80. PubMed ID: 20350943
[TBL] [Abstract][Full Text] [Related]
14. High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany.
Reinert RR; Lütticken R; Al-Lahham A
Clin Microbiol Infect; 2004 Jul; 10(7):659-62. PubMed ID: 15214881
[TBL] [Abstract][Full Text] [Related]
15. Associations of macrolide and fluoroquinolone resistance with molecular typing in Streptococcus pyogenes from invasive infections, 2010-2012.
Wajima T; Morozumi M; Chiba N; Shouji M; Iwata S; Sakata H; Ubukata K
Int J Antimicrob Agents; 2013 Nov; 42(5):447-9. PubMed ID: 23988719
[TBL] [Abstract][Full Text] [Related]
16. In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types.
Billal DS; Fedorko DP; Yan SS; Hotomi M; Fujihara K; Nelson N; Yamanaka N
J Antimicrob Chemother; 2007 Jan; 59(1):28-34. PubMed ID: 17065188
[TBL] [Abstract][Full Text] [Related]
17. Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: mechanisms of resistance and clonal diversity.
Albertí S; Cortés G; García-Rey C; Rubio C; Baquero F; García-Rodríguez JA; Bouza E; Aguilar L
Antimicrob Agents Chemother; 2005 Jan; 49(1):418-20. PubMed ID: 15616324
[TBL] [Abstract][Full Text] [Related]
18. Interspecies recombination in type II topoisomerase genes is not a major cause of fluoroquinolone resistance in invasive Streptococcus pneumoniae isolates in the United States.
Pletz MW; McGee L; Beall B; Whitney CG; Klugman KP
Antimicrob Agents Chemother; 2005 Feb; 49(2):779-80. PubMed ID: 15673766
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain.
Montes M; Tamayo E; Orden B; Larruskain J; Perez-Trallero E
Antimicrob Agents Chemother; 2010 Jan; 54(1):93-7. PubMed ID: 19805559
[TBL] [Abstract][Full Text] [Related]
20. Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes.
Balsalobre L; de la Campa AG
Antimicrob Agents Chemother; 2008 Mar; 52(3):822-30. PubMed ID: 18160515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
